‘Imperfect COP28’ Gives Direction For Managed, Equitable Move From Fossil Fuels

Celebrating the end COP28 which ended with an agreement to transition away from fossil fuels. Credit: UNFCCC

Celebrating the end of COP28, which ended with an agreement to transition away from fossil fuels. Credit: UNFCCC

By Cecilia Russell
DUBAI, Dec 14 2023 – While the outcomes of COP28 are being hotly debated in both the scientific and social justice arenas, the climate conference has taken an unprecedented step forward toward a just transition, says Yamide Dagnet, Director for Climate Justice at the Open Society Foundations.

Making some preliminary remarks a day after the climate conference ended, she said: “COP28 ends like it started: imperfect, yet an important and unprecedented step forward in our “course correction” for a just transition towards resilient and greener economies.”

The UN decision acknowledged the need for the decline of coal, oil, and gas for the first time in an agreement that talks about transitioning out of fossil fuels. It will also be known for operationalizing the Loss and Damages Fund, even if the funding falls far below the requirements for climate-stressed countries and communities.

UN Climate Change Executive Secretary Simon Stiell acknowledged these contractions in his final speech.

“While we didn’t turn the page on the fossil fuel era in Dubai, this outcome is the beginning of the end,” Stiell said.

He also noted that climate finance, which he said was a great enabler of climate action, fell short of the trillions needed to support developing countries with clean energy transitions and adaptation efforts.

He urged ordinary people everywhere to not relent in their demands for a climate-just world.

“In the crucial years ahead, your voices and determination will be more important than ever. I urge you never to relent. We are still in this race. We will be with you every single step of the way.”

Yamide Dagnet, Director for Climate Justice at Open Society Foundations. Credit: TJ Kirkpatrick, Open Society Foundations

Yamide Dagnet, Director for Climate Justice at Open Society Foundations. Credit: TJ Kirkpatrick, Open Society Foundations

Dagnet believes that COP28 is the start of a new era in climate justice.

“This is not an end; rather, just the beginning of an implementation journey that we know is hard but can be so positively transformative, and just if we manage to mobilize, in an equitable manner, all hands-on deck. A climate-just journey and outcome require vigilance, creativity, and accountability; stronger solidarity and engagement at all levels; promoting human rights; and shared prosperity for all,” she says.

This COP, Danget says, laid bare the issues with the Paris Agreement, especially with the just transition.

“More specifically, this COP exposed all the contradictions and challenges faced when implementing the promises of the Paris Agreement, especially a managed, equitable transition away from fossil fuels and the sustained mobilization, alignment, and access to financial flows domestically and internationally to decarbonize and build resilience,” Dagnet says. ”

While some signals got clearer with more substantive commitments, challenges remain, however, in how the just and equitable transition is sequenced.

“Inclusive processes matter to foster shared prosperity and benefits throughout the journey, together with adequate safeguards to minimize unintended adverse impacts of climate-related measures and technologies and to protect frontline and marginalized communities.

“Similarly, the just operationalization and continued capitalization of the Loss and Damage Fund will require vigilance, effective guidance, and mechanisms to make sure commensurate funding is actually mobilized and reaches the communities that need it the most in a timely manner. Adequate mobilization of finance for adaptation by the donor community is also essential to tackle losses and damages with dignity. We are happy that a dozen of them committed to join OSF efforts in this regard.”

IPS UN Bureau Report

 


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);  

Veson Nautical extends data analytics and collaboration capabilities with acquisition of Shipfix

BOSTON, Dec. 14, 2023 (GLOBE NEWSWIRE) — Veson Nautical (Veson), the global leader of maritime freight management solutions, today announced its acquisition of Shipfix, the collaborative data platform for the maritime and trade sectors driven by advanced AI–enabled tools. As Veson's second acquisition this year, Shipfix will further Veson's pursuit to deliver quality, contextual data to the industry. Veson will continue to offer Shipfix's suite of maritime solutions and bring the full Shipfix team onboard.

Shipfix was founded in 2018 to solve the email overload challenge encountered by chartering desks. By developing innovative products and groundbreaking AI–enabled tools, Shipfix provides a unique data platform allowing trade professionals to make smarter decisions and ultimately trade smarter and faster. Their product suite has expanded beyond front–line trading and chartering into operations teams and physical trading. Shipfix supports dry and tanker clients alongside other customers interested in freight market insights.

Shared clients will see the combined impact of Veson Nautical and Shipfix as Shipfix's pre–fixture data and insight capabilities are combined with Veson's existing end–to–end workflows to produce an unmatched freight trading and operations solution for the market. In addition, the data intelligence offerings from both Veson Nautical and Shipfix will become stronger through the consolidation, rationalization, and standardization of critical industry reference data.

John Veson, Co–founder and CEO at Veson Nautical, said: "A massive amount of data goes into pre–fixture decision–making. We're fortunate to have a growing integrated dataset that helps clients leverage contextual data across vessel specifications, ownership structures, commodities, trade flows, and tonnage flows, all in one place. I am thrilled to officially welcome Shipfix's expert team to Veson as we add their market–validated and accepted chartering and operations platform to our suite of solutions."

Antoine Grisay, Co–founder and Co–CEO at Shipfix said: "Together with Veson Nautical, we will deliver the ultimate integrated workflow and data experience shipping and trading companies have demanded for over a decade. We are very excited to start executing on the synergies between the companies. Our combined expertise will allow us to build a set of trading and operating insights that meet the increasingly sophisticated requirements of freight market participants."

Serge Alleyne, Co–founder and Co–CEO at Shipfix, said: "When Antoine and I founded Shipfix five years ago, our vision was to emerge as the ultimate solution for the maritime and trade community, commencing with an AI–powered collaboration platform and a suite of data insights products. Today, as Shipfix joins forces with Veson Nautical, it presents a unique opportunity for us to truly become the premier maritime platform, integrating best–in–class maritime expertise, data insights, and communication workflows from pre to post–fixtures. This union aims to maximise our clients' efficiency and operations in ways never seen before. It's the perfect match for us, leveraging extraordinary data and workflow synergies to accelerate our growth and consistently deliver maximum value for the entire shipping industry."

About Veson Nautical
Veson Nautical delivers maritime freight management solutions that propel the global shipping economy. Trusted by buyers and sellers of bulk marine freight in every region of the world, Veson solutions are responsible for managing $109 billion in freight traded and moving 4.4 billion tons in annual trade each year.

With a suite of offerings in marine freight trading and operations, vessel documentation, and data and analytics, Veson's products are widely recognized for their strong utility, sustained innovation, and measurable business impact.

Veson is a champion of progress that actively supports its clients, partners, and broader community in navigating change while shaping the best practice workflows and standards of tomorrow's connected maritime shipping ecosystem. Veson.com

About Shipfix
Shipfix is a collaborative workflow and data platform for the maritime and trade sectors, driven by ground–breaking AI–enabled tools. Shipfix went live in 2018 and has over a thousand users globally across more than 70 global clients. The platform streamlines maritime workflows using market and operational intelligence with a focus on shipowners, commodity traders, industrials, freight forwarders and shipbrokers. The company has 4 offices globally in Paris, London, Singapore and Tbilisi (Georgia).

With Shipfix, maritime and trade professionals make better–informed decisions and move faster. Users are enabled to find their market edge in highly volatile markets by turning their communications data into a competitive advantage. Shipfix is pioneering data transformation across the industry by enabling a subtle mix of artificial and human intelligence. Shipfix's software solutions include a front–end platform, a mobile app and a full API suite. www.shipfix.com

Media Contact
Claudia Norrgren
PR & Communications Manager
Veson Nautical
E: press@veson.com
C: +447736675334

Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/a29f3b8b–025b–432d–a434–cf9457db4ab4

https://www.globenewswire.com/NewsRoom/AttachmentNg/6dfafab9–ddf4–4bae–ac47–82cca0b62e40

https://www.globenewswire.com/NewsRoom/AttachmentNg/411c6d67–1882–49dd–b2bd–bcf6ae869af3

https://www.globenewswire.com/NewsRoom/AttachmentNg/6d18b7f8–3109–4746–a024–13b1a7a44750

https://www.globenewswire.com/NewsRoom/AttachmentNg/b69a8617–d800–4c6b–ba2d–f7c39409e27d


GLOBENEWSWIRE (Distribution ID 8994867)

EBRD Provides Footing for Youth-led Businesses in Central Asia

Credit: EBRD

By Anton Usov
ASTANA, Kazakhstan, Dec 14 2023 – The European Bank for Reconstruction and Development (EBRD) is addressing the issue of youth entrepreneurship and employment in Central Asia by launching a seven-year €200 million (US$ 218 million) Youth in Business (YiB) programme.

The programme is designed to provide better access to finance and relevant training to young entrepreneurs in the region, where up to one third of the population is aged between 18 and 34 years.

The Youth in Business programme in Central Asia (YiB CA) will target micro, small and medium-sized enterprises (MSMEs) led or owned by young individuals under the age of 35.

It will consist of up to €200 million for on-lending to up to 20 partner financial institutions in Central Asia and Mongolia; targeted non-financial services for eligible small businesses will be provided by the Bank’s Advice for Small Businesses programme to help develop their entrepreneurial skills through training, advisory services and networking opportunities.

The EBRD’s investment will be complemented by a package of up to €30 million consisting of grants and concessional co-financing to stimulate inclusive lending and youth entrepreneurship.

It is expected that the first loan agreements under the YiB CA will include: a loan of up to US$ 10 million to Uzbekistan’s largest private bank Hamkorbank, a loan of up to US$ 8 million to Shinhan Bank Kazakhstan, a loan of up to US$ 4 million to Mongolia’s leading micro lender Transcapital, and a loan of up to US$ 2 million to Kazakhstan-based microfinancial organisation Arnur Credit.

A market assessment conducted by the EBRD in the region reveals that while many young people across Central Asia have a strong entrepreneurial mindset, very few have access to equal economic opportunities. Only around 10 per cent of them have access to necessary training and professional expertise.

This is very important for Central Asia, where MSMEs account for almost half of total employment and contribute to almost 40 per cent of regional GDP.

Grant support and concessional finance to the programme is provided by the government of Kazakhstan, the Small Business Impact Fund and the European Union.

The EBRD is a leading institutional investor in Central Asia. It has to date provided close to €19 billion through more than 1,000 projects.

Anton Usov is EBRD Chief Spokesman for Central Asia and Mongolia

IPS UN Bureau

 


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);  

Kabul Residents Endure Hours-Long Queues in Severe Water Crisis

Women and children in Afghan cities endure hours-long queues for a vital resource—water. Credit: Learning Together

Women and children in Afghan cities endure hours-long queues for a vital resource—water. Credit: Learning Together

By External Source
Dec 14 2023 – According to United Nations statistics, nearly 80 percent of Afghan families lack access to sufficient water for their daily needs. Afghanistan, a landlocked country with limited water resources, is grappling with an exacerbated drought fueled by climate change, affecting the entire region.

In the western parts of Kabul, residents must endure lengthy queues, waiting for hours to secure the water they need.

To obtain drinking water, residents must travel considerable distances, enduring hours of waiting only to bring home a few barrels. Families designate someone to stand in line constantly, yet they still experience several days and nights without water

The situation has reached a critical point, exemplified by the district of Dasht-e-Barchi running out of water as temperatures rise. This crisis has persisted for months.

In the 13th district of Kabul city, the water company has suspended the water supply. Muhammad Ali and Juma, who have been living in the district for more than seven years, describe their plight as the worst they’ve experienced, emphasizing the absence of water and any communication from officials.

To obtain drinking water, residents must travel considerable distances, enduring hours of waiting only to bring home a few barrels. Families designate someone to stand in line constantly, yet they still experience several days and nights without water.

A private company that used to distribute water to people in exchange for money does not do it anymore. Residents say that there is no government water supply system in this area.

People can’t afford to dig their own wells. Therefore, they must wait for hours to get water from mosques and public distribution centers.

Groundwater levels in Kabul have dwindled significantly. In the Pole Khushk area, western Kabul, people wait from morning to evening for just one barrel of water, highlighting the severe impact of poverty and water scarcity on the city’s residents.

 

Water scarcity compounds the hardships of life in the Afghan capital, Kabul, adding to the misery of its residents. Credit: Learning Together

Water scarcity compounds the hardships of life in the Afghan capital, Kabul, adding to the misery of its residents. Credit: Learning Together

 

The Ministry of Energy and Water has plans to manage groundwater. The head of water program coordination, Rafiullah Stanakzai, says that there are several ongoing projects: the Kabul-Panjshir water canal project as well as the Shah Tut and the Shah Arous projects that supply water to Kabul. The work on these projects will begin after the technical team has reviewed them.

Officials attribute the decline in groundwater levels to population growth and excessive groundwater usage, underscoring the urgency of resolving the water crisis.

The water crisis needs a quick resolution. The Taliban government lacks a comprehensive plan to address the population’s needs for drinking water and essential necessities, casting a dark and hopeless shadow over the country plagued by drought.

A recent United Nations report highlights the gravity of the water crisis in Afghanistan:

  • Around 8 out of every 10 Afghan people drink unsafe water. 
  • 93% of children in Afghanistan (15.6 million children) live in areas of high, or extremely high, water vulnerability. 
  • Nearly 4.2 million people practice open defecation. 
  • 5 out of every 10 Afghan people don’t have access to at least basic sanitation facilities. 
  • Over 6 out of every 10 Afghan people don’t have access to basic hygiene facilities. 
  • Around 94% of schools across Afghanistan lack access to basic handwashing facilities. 
  • Around 35% of healthcare facilities lack access to at least a basic drinking water supply.

Excerpt:

The author is an Afghanistan-based female journalist, trained with Finnish support before the Taliban take-over. Her identity is withheld for security reasons

Sudan’s Conflict Needs Civil Society Solutions

Credit: El Tayeb Siddig/Reuters via Gallo Images

By Andrew Firmin
LONDON, Dec 14 2023 – It’s recently been reported that the two main protagonists of Sudan’s current conflict – leaders of the armed forces and militia at war since April – have agreed to face-to-face talks. The Intergovernmental Authority on Development (IGAD), an East African body, announced the potential breakthrough – although Sudan’s foreign ministry has since claimed IGAD’s statement is inaccurate, creating further uncertainty.

There’s no question that an end to the violence is urgently needed. The conflict has created a humanitarian and human rights crisis. But the two leaders involved, Abdel Fattah al-Burhan of the Sudanese Armed Forces (SAF) and Mohamad Hamdan Dagalo, known as Hemeti, of the Rapid Support Forces (RSF) militia, have provided ample evidence to doubt whether they’re really interested in peace, or in accountability for atrocities.

Human rights crimes on all sides

Al-Burhan and Hemeti were partners in the October 2021 coup that ousted the civilian government that followed the 2019 revolution. Their conflict began at a crunch moment for a supposed return to civilian rule and amid a plan to absorb the RSF into the SAF. As much as anything, it appears to be a personal power battle between the two leaders.

The conflict initially played out on the streets of the capital, Khartoum, and its neighbouring city of Omdurman. It has since spread to other regions. Other rebel groups are active, some acting independently of the two main forces.

All sides are targeting civilians, with clear evidence that war crimes and crimes against humanity are being committed. Over 12,190 people have been killed since the conflict began. The UN also estimates that 6.6 million people have now been displaced, the world’s highest number of displaced people.

The conflict has been brought to Darfur, the site of a genocide against local ethnic groups committed by the RSF and other Arab militias that began in 2003. Twenty years on, people are again being killed solely because of their ethnicity. The RSF now controls much of the region. In November, in response to the RSF’s ethnic cleansing, key Darfur militia groups joined the SAF’s side, signalling a further escalation of conflict.

The chaos of conflict has caused a cholera outbreak, with the health system collapsing and medical workers under attack. The World Food Programme has recently warned of a deepening hunger crisis.

In Chad, a low-income country home to around a million displaced people before the conflict began, refugee centres are struggling to cope with arrivals from Sudan and people live in crowded and insanitary conditions, exposed to continuing insecurity.

Humanitarian workers are being targeted. In December, two people were killed in an attack on a Red Cross convoy in Khartoum. Journalists are also being targeted, making it harder to get accurate and independent news from the ground. In Khartoum, the RSF has turned media buildings into detention centres.

And yet the response from the international community has been wholly inadequate. Recently the UN announced it had received only 38.6 per cent of the US$2.6 billion needed for humanitarian response in 2023. It’s only been able to help a fraction of those in need.

In another blow, at the start of December, the mandate of the UN Integrated Assistance Mission in Sudan was terminated at the request of the SAF-led government. Its job had been to support a democratic transition. The move offered a troubling sign that the government wants less rather than more international oversight.

A history of wishful thinking

With other conflicts dominating global headlines – first Ukraine, now Gaza – the world isn’t paying attention. But that doesn’t mean states have stopped taking sides. Sudan’s size, mineral wealth and geographical position give it strategic significance. Foreign states have long made self-interested calculations. Before the conflict, most states, as well as the UN, placed faith in the military as a source of stability. With that idea blown, states are now deciding which side is their best bet.

The United Arab Emirates is reportedly supplying arms to the RSF, and recently several of its diplomats were expelled by the foreign ministry. Russia is also on the RSF’s side. Both countries have an interest in Sudan’s gold. On the other side, Egypt has always been strongly behind the military establishment and the USA is said to be sliding towards the SAF as the perceived lesser of two evils.

Even when apparently well-intentioned, states and international organisations have consistently been guilty of wishful thinking. Before the conflict they put their faith in the promises of a military-led transition plan. Every process attempted since the coup has only further empowered the leaders now at war.

Need to enable civil society

It’s time Sudan’s civil society was heard and enabled to help pave the road to peace.

Sudan’s civil society is complex and layered. There’s an elite tier that broadly backed the supposedly transitional administration that emerged after the coup. There are established civil society organisations that work to provide essential services and advocate for rights. But the biggest source of opposition to armed rule has come from resistance committees: informal neighbourhood-level groups that played a crucial role in the 2019 revolution.

The committees are democratic and make decisions by consensus. They call for civilian rule and reject the calculations of the outside world about which form of military government can best guarantee stability, which for the resistance committees means continuing oppression. They’ve also become a key source of humanitarian response, including by providing food, water and healthcare.

Diverse resistance committees have worked together to develop a plan for transition to democracy. But the outside world seems perplexed, struggling to engage with a leaderless movement and rejecting demands for democratic civilian rule as somehow too ambitious.

But everything else has failed. There should be no route for either of the warring military leaders to retain power. When peace comes, so must accountability for human rights crimes. And neither will materialise unless democracy does – which means an enabled and empowered civil society.

Andrew Firmin is CIVICUS Editor-in-Chief, co-director and writer for CIVICUS Lens and co-author of the State of Civil Society Report.

 


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);  

Un nouveau comité consultatif de centre pour Fortrea

DURHAM, État de Caroline du Nord, 14 déc. 2023 (GLOBE NEWSWIRE) — Fortrea (Nasdaq : FTRE), ci–aprs la Socit , une organisation mondiale de recherche contractuelle de premier plan (ou CRO, de l'anglais Contract Research Organization), annonce ce jour que la premire runion de son comit consultatif de centre s'est tenue la semaine dernire. L'ordre du jour visait la collaboration entre les centres de recherche clinique, ci–aprs les centres et les leaders de l'industrie dans le but de crer une exprience amliore en matire d'essai clinique au bnfice des centres, des patients et des promoteurs d'tudes, ci–aprs les promoteurs , cibls sur les volutions technologiques, la planification oprationnelle et la prestation, les modalits commerciales et l'engagement communautaire.

Fortrea place les centres et les investigateurs au c"ur de la planification des essais cliniques, exploitant leurs perspectives pour amener des changements orients vers l'acclration des essais, la simplification du dmarrage des tudes, mais aussi l'optimisation du recrutement. Ces volutions constituent une rponse aux enjeux des essais cliniques, poss de longue date, et induiront une meilleure exprience pour les centres, les patients et les promoteurs. Le comit consultatif de centre sera charg d'apporter des clairages et des commentaires en lien avec les stratgies et les solutions proposes pour les centres, les patients, les essais et la technologie applicable.

Centres et investigateurs sont essentiels chaque tape du dveloppement clinique ; ils font habituellement face des enjeux complexes rien qu'en matire d'essais cliniques. Nous recueillons favorablement leurs avis lors de la conception des protocoles, et les faisons activement participer aux premiers dbats entre nos quipes oprationnelles et nos promoteurs pour dterminer rapidement la planification d'essais cliniques les plus efficaces et les mieux axs sur les patients observe Mike Clay, Vice–prsident de la stratgie de dveloppement et de croissance chez Fortrea. Et de poursuivre : La formation du comit consultatif de centre marque l'acclration de notre stratgie envers les centres, et rassemble autour de la table un groupe de rflexion sur notre industrie, compos d'minents leaders. Ce comit sera le pilier de notre aptitude rpondre aux promoteurs avec des concepts orients vers la prvisibilit de leurs essais. Nous travaillerons ensemble l'laboration de calendriers d'essais pertinents, et nous renforcerons leur confiance en acclrant la fois le processus de recrutement des patients et la conclusion globale des essais .

Les premiers membres du comit consultatif de centre de Fortrea comptent des leaders et des experts de Circuit Clinical, Elligo Health Research, FutureMeds, Javara, ObjectiveHealth, Pratia S.A., Velocity Clinical Research, et de la fondation espagnole et centre de recherche contre le cancer MD Anderson Cancer Center, soit 440 centres spcialiss dans plus de 25 domaines thrapeutiques, originaires de neuf pays, largissant ainsi l'accs toute une diversit de communauts de patients.

Opinions exprimes par les membres du comit consultatif de centre de Fortrea :

Selon ukasz Bczkowski, Directeur des oprations chez Pratia, Cette approche collaborative, runissant la fois les CRO et les centres, permettra un meilleur alignement de tous les acteurs de la recherche clinique envers les perspectives du march des essais cliniques, et nous donnera incontestablement une meilleure force de frappe. De telles initiatives sont capitales pour induire de rapides volutions positives .

Nick Spittal, Directeur des oprations de Velocity Clinical Research, estime que Fortrea a opt pour une approche privilgiant l'coute en confrant aux centres la possibilit de s'exprimer lgitimement sur les meilleures pratiques de travail pour dynamiser la fois les communauts de patients et les acteurs concerns de ces centres. Il en rsulte un meilleur service pour les promoteurs des essais cliniques .

D'aprs Barry Simms, Directeur des oprations d'Elligo Health Research, Fortrea se place la pointe de l'industrie en amliorant la productivit et l'efficacit des partenariats du processus d'essai jusqu'aux relations commerciales, tout en s'efforant d'acclrer la mise en march de nouveaux produits .

Pour la Directrice gnrale d'ObjectiveHealth, Colleen Hoke, Fournir une solution d'accs aux patients approprie est indispensable au succs d'un essai clinique. Les prestataires de soins de sant n'ont jusqu'ici pas t impliqus dans les premiers dbats visant la planification et la stratgie de recherche . Radek Janiak, Directeur gnral de FutureMeds, dclare Saluer l'approche innovante de Fortrea, axe sur l'change avec les organisateurs de partenariats des tablissements de sant, essentiels la russite prcoce des rsultats de recherche dans le processus de planification.

FutureMeds se rjouit de rejoindre le comit consultatif de centre de Fortrea pour contribuer la meilleure comprhension entre les acteurs cls de la recherche clinique . Enfin, pour Michelle Rule, Vice–prsidente en chef de l'optimisation professionnelle chez Javara, Entendre la voix des patients, des investigateurs et des centres placera Fortrea en pole position pour introduire de nouveaux traitements sur le march.

Naviguer le gigantesque cosystme des essais cliniques est complexe et ncessite des partenariats trs fonctionnels, centrs sur la confiance et la comptence. Fortrea s'engage vritablement en faveur du dialogue et des relations de travail travers son comit consultatif de centre, qui tmoigne de son dvouement envers le progrs visant toutes les parties prenantes de la recherche, et surtout les patients .

propos de Fortrea

Fortrea (Nasdaq : FTRE) figure parmi les principaux fournisseurs de solutions de dveloppement clinique et d'accs aux soins pour les patients dans le secteur mondial des sciences de la vie. Fortrea s'associe des socits tablies et mergentes du domaine biopharmaceutique, des dispositifs mdicaux et des diagnostics pour stimuler l'innovation en matire de sant, et acclrer la mise au point de traitements rvolutionnaires pour les patients qui en ont besoin. Nous proposons des services de gestion d'essais cliniques de phase I IV, de pharmacologie clinique, d'essais diffrencis axs sur des technologies habilitantes, et des services post–autorisation. Nos solutions s'appuient sur 30 ans d'exprience dans 20 domaines thrapeutiques, une passion pour la rigueur scientifique, des connaissances exceptionnelles et un solide rseau de centres de recherche. Notre quipe talentueuse et diversifie d'environ 19 000 collaborateurs rpartis sur plus de 90 pays est dimensionne pour fournir des solutions cibles et agiles nos clients, partout dans le monde. Pour en savoir plus sur la manire dont Fortrea est moteur d'influence du pipeline au patient, rendez–vous sur Fortrea.com et suivez–nous sur LinkedIn et X (anciennement Twitter) @Fortrea.

Coordonnes de Fortrea :
Relations mdias auprs de Fortrea : Galen Wilson "" 703–298–0802, media@fortrea.com
Mdias : Kate Dillon "" 646–818–9115, kdillon@prosek.com


GLOBENEWSWIRE (Distribution ID 8994772)

Fortrea beruft neuen Prüfzentrumsbeirat ein

DURHAM, North Carolina, Dec. 14, 2023 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (das "Unternehmen"), ein weltweit fhrendes Auftragsforschungsinstitut (Contract Research Organization, CRO), gab heute die Einberufung der ersten Sitzung seines Prfzentrumsbeirats in der vergangenen Woche bekannt. Dabei handelt es sich um eine Zusammenarbeit zwischen Prfzentren fr klinische Forschung ("Prfzentren") und fhrenden Unternehmen der Branche, um die Erfahrungen mit klinischen Studien fr Prfzentren, Patienten und Sponsoren von klinischen Studien ("Sponsoren") zu verbessern, indem Vernderungen in den Bereichen Technologie, operative Planung und Durchfhrung, kommerzielle Bedingungen und gesellschaftliches Engagement angestrebt werden.

Fortrea stellt Prfzentren und Prfrzte in den Mittelpunkt der Planung klinischer Studien und nutzt ihre Perspektive, um nderungen voranzutreiben, die die Durchfhrung von Studien beschleunigen, den Studienbeginn erleichtern und die Effizienz der Rekrutierung erhhen. Mit diesen nderungen sollen seit langem bestehende Probleme bei klinischen Prfungen angegangen und die Erfahrungen von Prfzentren, Patienten und Sponsoren verbessert werden. Der Prfzentrumsbeirat ist knftig fr die Bereitstellung von Einblicken und Rckmeldungen zu Strategien und Lsungen verantwortlich, die in Bezug auf Prfzentren, Patienten, Studienbetrieb und relevante Technologie vorgeschlagen werden.

"Prfzentren und Prfer sind in jeder Phase der klinischen Entwicklung von entscheidender Bedeutung fr die Branche und standen in der Vergangenheit bei klinischen Prfungen meist allein vor schwer zu lsenden Herausforderungen. Wir begren ihre Einblicke in die Gestaltung von Prfplnen und mchten sie aktiv in frhe Gesprche mit unseren operativen Teams und Sponsoren einbinden, um schnell die effizientesten, patientenorientierten Prfplne zu erstellen", so Mike Clay, Vice President, Development Strategy and Growth, bei Fortrea. "Die Grndung des Prfzentrumsbeirats stellt eine Beschleunigung unserer auf Prfzentren ausgerichteten Strategie dar und umfasst unglaublich beeindruckende Fhrungspersnlichkeiten, die einen Think Tank fr unsere Branche bilden. Der Beirat wird auch ein Eckpfeiler unserer Fhigkeit sein, Sponsoren mit Erkenntnissen zu versorgen, die die Vorhersagbarkeit ihrer Studien verbessern, indem wir gemeinsam effiziente operative Plne entwickeln und den Sponsoren ein hohes Ma an Vertrauen in die Geschwindigkeit der Patientenrekrutierung und die gesamte Studienumsetzung bieten."

Zu den Grndungsmitgliedern des Prfzentrumsbeirats von Fortrea gehren fhrende Persnlichkeiten und Experten von Circuit Clinical, Elligo Health Research, FutureMeds, Javara, MD Anderson Cancer Center Foundation Spain, ObjectiveHealth, Pratia S.A. und Velocity Clinical Research, die 440 Prfzentren auf mehr als 25 Therapiegebieten und in neun Lndern reprsentieren und Zugang zu verschiedensten Patientengruppen bieten.

Was die Mitglieder des Prfzentrumsbeirats von Fortrea sagen …

"Wir sind fest davon berzeugt, dass dieser kooperative Ansatz, der sowohl CROs als auch Prfzentren zusammenbringt, es allen Beteiligten ermglichen wird, die Perspektiven auf dem Markt fr klinische Studien effektiver abzustimmen", so ukasz Bczkowski, Chief Operating Officer bei Pratia. "Dies gibt uns zweifelsohne die Mglichkeit, gemeinsam effizienter zu handeln. Initiativen wie diese spielen eine entscheidende Rolle dabei, uns alle zu positiven und schnellen Vernderungen anzutreiben."

"Fortrea verfolgt einen Ansatz des "Zuhrens", indem es den Prfzentren ein gleichberechtigtes Mitspracherecht einrumt, wenn es darum geht, die effektivsten Arbeitsmethoden fr die dynamischen Patientengemeinschaften und die Interessenvertreter der Prfzentren zu finden, was zu einem optimalen Service fr die Sponsoren klinischer Studien fhrt", so Nick Spittal, Chief Operations Officer bei Velocity Clinical Research.

"Fortrea ist fhrend in der Branche, wenn es darum geht, Partnerschaften produktiver und effizienter zu gestalten, vom Studienprozess bis zu den Geschftsbeziehungen, um neue Produkte schneller auf den Markt zu bringen", so Barry Simms, Chief Operating Officer bei Elligo Health Research.

"Die Bereitstellung einer geeigneten Lsung fr den Patientenzugang ist fr den letztendlichen Erfolg einer klinischen Studie entscheidend. In der Vergangenheit waren die Leistungserbringer nicht in die frhe Entwicklung der Forschungsplanung und –strategie eingebunden", so Colleen Hoke, Chief Executive Officer bei ObjectiveHealth. "Wir begren es ausdrcklich, dass Fortrea einen innovativen neuen Ansatz verfolgt, um bereits in einem frhen Stadium des Planungsprozesses mit den Anbietern von Partnerschaften im Gesundheitswesen zusammenzuarbeiten, die fr die Erzielung erfolgreicher Forschungsergebnisse entscheidend sind."

"FutureMeds ist erfreut, dem Prfzentrumsbeirat von Fortrea beizutreten, um ein besseres Verstndnis zwischen den Hauptakteuren der klinischen Forschungsindustrie zu schaffen", so Radek Janiak, Chief Executive Officer bei FutureMeds. "Wenn wir die Stimme von Patienten, Prfrzten und Prfzentren hren, wird Fortrea in der Pole Position sein, um neue Therapien auf den Markt bringen zu knnen."

"Die Arbeit im riesigen kosystem der klinischen Studien ist komplex und erfordert hochfunktionale Partnerschaften, die auf Vertrauen und Kompetenz basieren", so Michelle Rule, Senior Vice President of Enterprise Optimization bei Javara. "Das echte Engagement von Fortrea fr den Aufbau eines Forums und von Arbeitsbeziehungen durch den Prfzentrumsbeirat zeigt, dass sich das Unternehmen fr alle Beteiligten in der Forschung und vor allem fr die Patienten einsetzt."

ber Fortrea

Fortrea (Nasdaq: FTRE) ist ein weltweit fhrender Anbieter von Lsungen fr die klinische Entwicklung und den Zugang zu Patienten in der Biowissenschaftsbranche. Wir arbeiten mit aufstrebenden und groen biopharmazeutischen, medizintechnischen und diagnostischen Unternehmen zusammen, um Innovationen im Gesundheitswesen voranzutreiben, die lebensverndernde Therapien fr bedrftige Patienten beschleunigen. Fortrea bietet Management von klinischen Studien der Phasen I–IV, klinische Pharmakologie, differenzierte technologiegesttzte Studienlsungen und Dienstleistungen nach der Zulassung. Die Lsungen von Fortrea basieren auf drei Jahrzehnten Erfahrung in mehr als 20 Therapiegebieten, einer Leidenschaft fr wissenschaftliche Strenge, auergewhnlichen Erkenntnissen und einem starken Netzwerk von Prfzentren. Unser talentiertes und vielseitiges Team von etwa 19.000 Mitarbeitern in ber 90 Lndern ist so skaliert, dass wir unseren Kunden weltweit gezielte und flexible Lsungen anbieten knnen. Erfahren Sie mehr darber, wie Fortrea zu einer transformativen Kraft von der Pipeline bis zum Patienten wird, unter Fortrea.com und folgen Sie uns auf LinkedIn und X (frher Twitter) @Fortrea.

Kontakt zu Fortrea:
Fortrea "" Medien: Galen Wilson "" 703–298–0802, media@fortrea.com
Fortrea "" Medien: Kate Dillon "" 646–818–9115, kdillon@prosek.com


GLOBENEWSWIRE (Distribution ID 8994772)

Fortrea Convoca Novo Conselho Consultivo de Locais

DURHAM, N.C., Dec. 14, 2023 (GLOBE NEWSWIRE) — A Fortrea (Nasdaq: FTRE) (a "Empresa"), uma organizao lder global de pesquisa por contrato (CRO), anunciou hoje que convocou na semana passada a reunio inaugural do seu Conselho Consultivo de Locais, uma colaborao entre locais de pesquisa clnica ("locais") e lderes da indstria para criar uma melhor experincia de ensaio clnico para locais, pacientes e patrocinadores de estudos clnicos ("patrocinadores"), visando mudanas na tecnologia, planejamento e entrega operacional, termos comerciais e envolvimento da comunidade.

A Fortrea coloca as unidades e os investigadores na vanguarda do planejamento de ensaios clnicos, utilizando suas perspectivas para impulsionar mudanas para o aprimoramento da velocidade da execuo do ensaio, facilidade do incio do estudo e aumento da eficincia do recrutamento. Essas mudanas abordam desafios de longa data para os ensaios clnicos e resultaro em uma melhor experincia do estudo no local, no paciente e no patrocinador. O Conselho Consultivo de Locais ser responsvel por fornecer informaes e feedback sobre estratgias e solues propostas em relao aos locais, pacientes, operaes de teste e tecnologia relevante.

"Os locais e os pesquisadores so fundamentais para a indstria em todas as fases do desenvolvimento clnico, e tradicionalmente enfrentam desafios difceis de resolver apenas em ensaios clnicos. Damos as boas–vindas aos seus insights sobre o design do protocolo e os convidamos a participarem ativamente das conversas iniciais com nossas equipes operacionais e patrocinadores para o rpido estabelecimento dos planos de estudo mais eficientes e focados no paciente", disse Mike Clay, vice–presidente de Estratgia de Desenvolvimento e Crescimento da Fortrea. "A formao do Conselho Consultivo de Locais acelera a nossa estratgia focada nos Locais e inclui a representao de lderes incrivelmente impressionantes, criando um think tank para a nossa indstria. O Conselho tambm servir como uma pedra angular para a nossa capacidade de responder aos patrocinadores com insights que melhorem a previsibilidade dos seus ensaios, trabalhando juntos para desenvolver planos operacionais eficientes e fornecer aos patrocinadores um alto grau de confiana na velocidade do recrutamento de pacientes e na entrega geral do ensaio."

Os membros inaugurais do Conselho Consultivo de Locais da Fortrea incluem lderes e especialistas da Circuit Clinical, Elligo Health Research, FutureMeds, Javara, MD Anderson Cancer Center Foundation Spain, ObjectiveHealth, Pratia S.A. e Velocity Clinical Research, representando 440 locais em mais de 25 reas teraputicas e nove pases, e fornecendo acesso a diversas comunidades de pacientes.

O que os membros do Conselho Consultivo de Locais da Fortrea esto dizendo…

"Acreditamos firmemente que essa abordagem colaborativa, reunindo o CRO e as unidades, permitir que todas as partes interessadas se alinhem de forma mais eficaz s perspectivas do mercado de ensaios clnicos", disse ukasz Bczkowski, diretor de operaes da Pratia. "Isso, sem dvida, nos capacita a agir juntos de maneira mais eficiente. Iniciativas como essas so essenciais para impulsionar todos ns em direo a mudanas positivas e rpidas."

"A Fortrea est adotando uma abordagem de "ouvir primeiro", dando aos locais uma voz igual para as prticas de trabalho mais eficazes para comunidades dinmicas de pacientes e partes interessadas no local, resultando em um melhor servio para os patrocinadores de ensaios clnicos", disse Nick Spittal, diretor de operaes da Velocity Clinical Research.

"A Fortrea est liderando o setor para tornar as parcerias mais produtivas e eficientes, desde o processo de teste at as relaes comerciais, tudo no esforo de acelerar o lanamento de novos produtos no mercado", disse Barry Simms, diretor de operaes da Elligo Health Research.

"Uma soluo de acesso ao paciente apropriada essencial para determinar o sucesso final de um ensaio clnico. Historicamente, os prestadores de cuidados no participam do desenvolvimento inicial do planejamento e da estratgia da pesquisa", disse Colleen Hoke, diretora executiva da ObjectiveHealth. "Apoiamos muito a Fortrea no emprego de uma nova abordagem inovadora para envolvimento com os provedores de parcerias de locais de sade, que so fundamentais para a obteno de resultados de pesquisa bem–sucedidos, desde o incio do processo de planejamento."

"A FutureMeds tem o prazer de fazer parte do Conselho Consultivo de Locais da Fortrea para criar um melhor entendimento entre as principais partes interessadas no setor de pesquisa clnica", disse Radek Janiak, diretor executivo da FutureMeds. "Ao ouvir os pacientes, pesquisadores e locais a Fortrea passa a ter uma posio de destaque para a oferta de novas terapias no mercado."

"O trabalho com o vasto ecossistema de ensaios clnicos complexo e requer parcerias altamente funcionais centradas na confiana e na competncia", disse Michelle Rule, vice–presidente snior de otimizao empresarial da Javara. "O compromisso genuno da Fortrea com a criao de um frum e relaes de trabalho por meio do Conselho Consultivo de Locais um exemplo da dedicao ao progresso de todas as partes interessadas na pesquisa e, acima de tudo, dos pacientes."

Sobre a Fortrea

A Fortrea (Nasdaq: FTRE) fornecedora lder global de solues para o desenvolvimento clnico e acesso ao paciente para a indstria de cincias da vida. Fazemos parcerias com grandes e emergentes empresas biofarmacuticas, de dispositivos mdicos e de diagnstico para impulsionar a inovao na sade que acelera terapias que mudam a vida dos pacientes que precisam delas. A Fortrea fornece gerenciamento de testes clnicos de fase I–IV, farmacologia clnica, solues de testes com tecnologia diferenciada e servios ps–aprovao. As solues da Fortrea utilizam suas trs dcadas de experincia abrangendo mais de 20 reas teraputicas, sua dedicao ao rigor cientfico, insights excepcionais e uma forte rede de pesquisadores. Nossa equipe talentosa e diversificada de aproximadamente 19.000 pessoas que trabalham em mais de 90 pases dimensionada para fornecer solues focadas e geis para clientes de todo o mundo. Saiba mais sobre como a Fortrea est se tornando uma fora transformadora de pipeline para paciente na Fortrea.com e siga–nos no LinkedIn e X (antigo Twitter) @Fortrea.

Contatos da Fortrea:
Fortrea para Mdia: Galen Wilson "" 703–298–0802, media@fortrea.com
Fortrea para Mdia: Kate Dillon "" 646–818–9115, kdillon@prosek.com


GLOBENEWSWIRE (Distribution ID 8994772)